$MIRM news
The latest MIRM stock news: headlines, filings, AI summaries and sentiment for $MIRM, updated around the clock.
- Mirum Pharmaceuticals Announces Positive Late-Stage Trial Results for Hepatitis D Drug Brelovitug
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- Mirum Pharmaceuticals Reports Q3 2026 Revenue Growth Driven by LIVMARLI
- Mirum Pharmaceuticals Projects 2026 Net Product Sales Between $715M and $720M
- Mirum Pharmaceuticals Reports Q3 Revenue Beat Amid GAAP EPS Miss
- Mirum Pharmaceuticals, Inc. - 10-Q Filing
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- Mirum's Livmarli Meets Primary Endpoint in Phase 3 Trial for Cholestatic Pruritus
- Mirum Pharmaceuticals Announces Topline Results for Livmarli Trial
- Mirum Pharmaceuticals Shares Drop Despite Positive Phase 3 Trial Data for Hepatitis D Treatment
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- FDA Approves Mirum and Incyte's Atebrioz for Rare Bone Disorder FOP
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- Mirum Pharmaceuticals Reports Positive Phase 2b Data for Volixibat in PSC
- Mirum Pharmaceuticals Reports Strong Revenue Growth and Raised Guidance for 2026
- Mirum Pharmaceuticals, Inc. - 8-K Filing
- Mirum Pharmaceuticals Reports Q1 2026 Earnings and Financial Performance